Moffitt Cancer Center funding

[RandyW]

Moffit Cancer Center wins $5M award for clinical trials

Tampa Bay Business Journal - 2:53 PM EST Tuesday

Print this Article Email this Article Reprints RSS Feeds Most Viewed Most Emailed

The National Institutes of Health has awarded a $4.8 million contract to the H. Lee Moffitt Cancer Center & Research Institute to promote Phase II clinical trials.

Dr. Daniel Sullivan, associate center director for clinical investigations, accepted the awards, a release said.

The contract "Early Therapeutics Development with Phase II Emphasis," opened Jan. 1 and lasts through the end of Dec. 2008 with a possibility of $3.2 million of more funding for an additional two years. Moffitt doctors in this study include Scott Antonia, Adil Daud, Jeffrey Lancet, Pamela Munster, George Simon, Andy Trotti, JungSun Choi, Doug Letson and Martin Silbiger.

Dr. Chris Garrett, member of the Gastrointestinal Tumor Program is the co-principal investigator.

The goal of the trials is to assess the response to a specific drug or drug combination for patients with the same cancer type and taking samples of the tumors or blood for correlative research studies. The first cancers being studied are acute myeloid leukemia, kidney and lung.

As principal investigator of this contract, Sullivan serves on the National Cancer Institute's Investigational Drug Steering Committee. This committee provides input to the federal government and works to design better clinical trials.

In 2001, the National Cancer Institute awarded Moffitt the status of a Comprehensive Cancer Center in recognition of its excellence in research and contributions to clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, an alliance of the country's most visible cancer centers. Its sole mission is to contribute to the prevention and cure of cancer.

On a personal Note;

Moffitt recieved as memorial donation for deb when she passed. I think they are great.